NEOGENOMICS INC — Director's Dealing 2022

Aug 18, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2022-08-15

Reporting Person: Smith Christopher M (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-15	Common Stock	A	336767	—	Acquired	336767	Direct
2022-08-15	Common Stock	A	265452	—	Acquired	602219	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-15	Stock Option (Right to Buy)	$12.62	A	694444	Acquired	2029-08-15	Common Stock (694444.0)	Direct

Footnotes

F1: On August 15, 2022, Mr. Smith was granted 336,767 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.

F2: On August 15, 2022, Mr. Smith was granted 265,452 restricted stock awards. These awards vest on the fourth anniversary date of the grant date.

F3: On August 15, 2022, Mr. Smith was granted 694,444 stock options. These options vest ratably over the first four anniversary dates of the grant date.